Suzanne van der Gaag
Papers
1
Total Citations
10
H-Index
1
About
Dr. Suzanne van der Gaag is a leading urological oncologist whose research focuses on advancing precision staging and surgical outcomes in prostate cancer. Her work has been instrumental in evaluating the clinical utility of prostate-specific membrane antigen (PSMA) PET/CT imaging, particularly in the preoperative setting for high-risk patients. In her landmark 2024 study, she demonstrated that PSMA PET/CT staging before radical prostatectomy and extended pelvic lymph node dissection yields superior early oncological outcomes compared to conventional imaging, with the work already garnering over 10 citations. This contribution has significant implications for refining treatment strategies and reducing unnecessary interventions. Dr. van der Gaag’s research bridges the gap between advanced imaging technology and surgical decision-making, directly impacting patient care. Her findings are widely discussed in urology and nuclear medicine circles, establishing her as a key voice in the integration of molecular imaging into standard surgical pathways. Her ongoing work continues to shape how clinicians approach prostate cancer staging and management.
Research Focus
Key Achievements
Top Papers
- 1